Search...
Features
Assets
Blog
Help
Learn
Get App
Login
Sign Up
Get App
Galmed Pharmaceuticals (GLMD) Q4 2022 Earnings
GLMD
29
Mar
Confirmed
Aug 22
Nov 22
Jan 23
Q4 2022
-0.24
-0.19
-0.15
-0.1
Details
Expected EPS
-0.14
Actual EPS
-0.1
Surprise EPS
0.04
Surprise Percent
+28.57%
Description
Galmed Pharmaceuticals (GLMD) has reported earnings of -0.1 per share for Q4 2022.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login